gip glp 1 tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Frontiers | GLP-1/GIP dual agonist

A major contributor was prescription drug spending, which rose 9.4% in 2025, driven in part by growing use of GLP-1 medications, some of which have list prices exceeding $1,000 per month, according to various estimates

PlexusDx GLP-1 medications are HSA and FSA eligible, allowing uninsured patients to redirect tax-advantaged savings toward treatment

Patients treated with Saxenda should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior

Bodybuilding Health+ offers compounded semaglutide and tirzepatide, which are not FDA-approved finished products and outcomes are not guaranteed

For example, liraglutide, a GLP-1 receptor agonist, improved cognitive function in n = 19 patients with major depressive disorder (MDD) or bipolar disorder in a pilot randomised controlled trial (RCT) [16], whilst a systematic review and meta-analysis reported a pooled reduction in depressive symptoms with GLP-1 receptor agonists compared to other antidiabetic therapies [17]

Hydration compounds the importance of electrolytes